Clinical Trial Update: Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose safety study of denosumab 120 mg in adults with severe chronic kidney disease, including those on dialysis, completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED | Results posted: 2016-02-19